Azenta Life Sciences, formerly GENEWIZ routinely sequences pre-made amplicons on Illumina platforms to answer a myriad of biological questions. Standard amplicon sequencing provides flexible data requirements for amplicons starting at 100 bp in size. Amplicons can either be fragmented or sequenced contiguously depending on their size and the purpose of your project.
Applications for this service span many different research areas. Scientists commonly sequence amplicons for antibody library screening, natural antibody repertoire profiling, disease genotyping, genome editing (i.e. CRISPR) mutation analysis, screening of molecular clones, and analysis of plasmid stocks – to name a few.
Azenta accepts purified and unpurified amplicons, restriction digested material, fragmented DNA, and plasmids. For detailed sample submission requirements please visit our Sample Submission Guidelines.
For information on our NGS platforms as well as recommended configurations of your projects, please visit the NGS Platforms page. Azenta does not guarantee data output or quality for sequencing-only projects.